Anthony Fusco

Anthony Fusco currently serves as the Global Portfolio Analytics Lead at Alexion Pharmaceuticals, Inc., a position held since 2024. Prior to this role, Anthony was associated with Partner Therapeutics from 2019 to 2024, where responsibilities included Executive Director and various leadership positions focusing on new product planning and COVID initiatives. Earlier experience includes a consulting role at L.E.K. Consulting and an MBA internship at Health Advances. Anthony's foundational career began as an Assay Development Scientist at Abcam, followed by a Research Scientist role at Firefly Bioworks, alongside multiple co-op positions in research and development across diverse organizations. Anthony holds an MBA from Harvard Business School and a Bachelor of Science in Chemical Engineering from Northeastern University.